1. Home
  2. CVCO vs LQDA Comparison

CVCO vs LQDA Comparison

Compare CVCO & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CVCO

Cavco Industries Inc. When Issued

N/A

Current Price

$605.82

Market Cap

4.8B

ML Signal

N/A

LQDA

Liquidia Corporation

N/A

Current Price

$45.22

Market Cap

3.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVCO
LQDA
Founded
1965
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
3.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CVCO
LQDA
Price
$605.82
$45.22
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
★ $662.00
$54.38
AVG Volume (30 Days)
75.6K
★ 5.5M
Earning Date
10-29-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
★ 51.81
EPS
★ 5.43
1.26
Revenue
★ $2,142,713,000.00
$158,320,000.00
Revenue This Year
$9.17
$357.27
Revenue Next Year
$7.74
$1.34
P/E Ratio
$100.27
★ $35.65
Revenue Growth
31.68
★ 1031.18
52 Week Low
$443.34
$22.22
52 Week High
$713.01
$93.61

Technical Indicators

Market Signals
Indicator
CVCO
LQDA
Relative Strength Index (RSI) 66.18 51.26
Support Level $558.79 $35.00
Resistance Level $630.48 $46.67
Average True Range (ATR) 21.27 2.88
MACD 6.65 2.62
Stochastic Oscillator 78.83 89.61

Price Performance

Historical Comparison
CVCO
LQDA

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes distributed through a network of independent and company-owned retailers, planned community operators and residential developers. It is also a producer of park model RVs, vacation cabins and Factory-built commercial structures. It operates principally in two segments: factory-built housing, which includes wholesale and retail factory-built housing operations and Financial services, which include manufactured housing consumer finance and insurance. The factory-built housing segment generates the majority of revenue from building and selling manufactured and modular homes to both wholesale customers and end consumers through company owned retail stores.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: